Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;16(3):196-206.
doi: 10.5114/pg.2021.109063. Epub 2021 Sep 17.

Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis

George Koulaouzidis  1 , Dafni Charisopoulou  2   3 , Michał Kukla  4   5 , Wojciech Marlicz  6   7 , Grażyna Rydzewska  8   9 , Anastasios Koulaouzidis  10 , Karolina Skonieczna-Żydecka  1
Affiliations

Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis

George Koulaouzidis et al. Prz Gastroenterol. 2021.

Abstract

Introduction: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, which is estimated to affect 20-30% of the adult population in Europe. Several studies have shown an association of NAFLD with multiple cardiovascular risk factors such as abdominal obesity, atherogenic dyslipidaemia, hypertension, insulin resistance, and impaired glucose tolerance. Atherosclerosis is a chronic, progressive, inflammatory disease, which begins early in life and follows a long asymptomatic phase. Coronary artery calcification (CAC) is the radiological confirmation of the presence of atherosclerotic coronary artery disease. The predictive value of CAC for future cardiac events is well established. Also, the progression of CAC is strongly associated with the development of cardiovascular events.

Aim: To assess the association of NAFLD with the progression of subclinical atherosclerotic activity, reflected as the dynamic changes in CAC score over time.

Material and methods: The databases PubMed/Medline/Embase from inception until 31 December 2020 were searched for observational studies investigating NAFLD and CAC progression in adults.

Results: In total, 5 studies were included, 4 of which, including 10,060 patients, provided data regarding the association of NAFLD with the progression of CAC. The analysis showed that NAFLD is associated with significant odds of progression of CAC; OR = 1.5, 95% CI: 1.34-1.68, p = 0.001. No publication bias was detected (Egger's test p = 0.6). Meta-regression analyses proved that OR toward CAC progression is not significantly influenced by the time of follow-up (coefficient = 0.0083, Z = 1.14, p = 0.25).

Conclusions: NAFLD increases the risk toward CAC progression over time.

Keywords: calcium score; coronary artery calcification; metabolic-associated fatty liver disease; non-alcoholic fatty liver disease; subclinical atherosclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Study flow chart
Figure 2
Figure 2
Odds ratio for progression of CAC regarding NAFLD phenotype. Q = 1.73, df(Q) = 3, p = 0.63, I2 = 0.00
Figure 3
Figure 3
Funnel plot for OR toward CAC progression in the present meta-analysis
See this image and copyright information in PMC

References

    1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31. - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, et al. . Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73-84. - PubMed
    1. Satapathy SK, Sanyal AJ. Epidemiology and natural history of nonalcoholic fatty liver disease. Semin Liver Dis 2015; 35: 221-35. - PubMed
    1. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-85. - PubMed
    1. Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 2017; 66: 1138-53. - PubMed